Granahan Investment Management - Q3 2021 holdings

$5.27 Billion is the total value of Granahan Investment Management's 193 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 27.3% .

 Value Shares↓ Weighting
MGNI BuyMAGNITE INC$200,554,000
-8.4%
7,162,652
+10.7%
3.80%
-6.8%
EVH BuyEVOLENT HEALTH INCcl a$149,220,000
+48.2%
4,813,553
+1.0%
2.83%
+50.9%
APPS BuyDIGITAL TURBINE INC$149,164,000
+2.2%
2,169,653
+13.0%
2.83%
+4.0%
ETSY BuyETSY INC$138,133,000
+12.6%
664,230
+11.4%
2.62%
+14.7%
PRCH BuyPORCH GROUP INC$94,661,000
+1.1%
5,354,138
+10.6%
1.80%
+2.9%
ARRY BuyARRAY TECHNOLOGIES INC$77,408,000
+346.9%
4,179,692
+276.4%
1.47%
+354.8%
SPT BuySPROUT SOCIAL INC$60,513,000
+39.4%
496,213
+2.2%
1.15%
+41.9%
OSTK BuyOVERSTOCK COM INC DEL$56,996,000
+12.6%
731,462
+33.3%
1.08%
+14.6%
TDUP BuyTHREDUP INCcl a$46,306,000
+504.3%
2,134,881
+710.2%
0.88%
+514.7%
MSP BuyDATTO HLDG CORP$40,104,000
+4.6%
1,678,010
+21.8%
0.76%
+6.4%
LQDT BuyLIQUIDITY SVCS INC$38,655,000
-13.3%
1,788,742
+2.1%
0.73%
-11.8%
ZETA BuyZETA GLOBAL HOLDINGS CORPcl a$35,136,000
-24.0%
5,995,934
+8.9%
0.67%
-22.5%
LAD BuyLITHIA MTRS INC$33,392,000
+48.1%
105,325
+60.5%
0.63%
+51.0%
VRNS BuyVARONIS SYS INC$31,007,000
+6.3%
509,570
+0.6%
0.59%
+8.1%
ORGO BuyORGANOGENESIS HLDGS INC$30,217,000
-13.8%
2,122,005
+0.6%
0.57%
-12.3%
CSTL BuyCASTLE BIOSCIENCES INC$29,990,000
-8.0%
450,980
+1.4%
0.57%
-6.3%
CXM BuySPRINKLR INCcl a$29,069,000
+2.4%
1,661,084
+20.5%
0.55%
+4.3%
FLEX BuyFLEX LTDord$26,158,000
+11.4%
1,479,545
+12.6%
0.50%
+13.5%
NewRISKIFIED LTD$25,708,0001,127,069
+100.0%
0.49%
JRVR BuyJAMES RIV GROUP LTD$24,531,000
+2.9%
650,184
+2.3%
0.46%
+4.7%
ICAD BuyICAD INC$24,108,000
+18.7%
2,242,603
+91.2%
0.46%
+20.9%
LXFR BuyLUXFER HOLDINGS PLC$23,678,000
+6.2%
1,206,230
+20.4%
0.45%
+8.2%
SSTI BuySHOTSPOTTER INC$23,496,000
-23.3%
646,030
+2.8%
0.45%
-21.9%
WSC BuyWILLSCOT MOBIL MINI HLDNG CO$22,600,000
+18.8%
712,497
+4.4%
0.43%
+21.2%
CSSE BuyCHICKEN SOUP FOR THE SOUL ENcl a$22,492,000
-29.3%
983,484
+27.9%
0.43%
-28.0%
GRBK BuyGREEN BRICK PARTNERS INC$22,436,000
+325.0%
1,093,372
+371.0%
0.43%
+334.7%
ALTG BuyALTA EQUIPMENT GROUP INC$21,189,000
+20.9%
1,543,234
+17.0%
0.40%
+22.9%
EVER BuyEVERQUOTE INC$21,085,000
-21.3%
1,131,777
+38.0%
0.40%
-19.8%
CHEF BuyCHEFS WHSE INC$20,954,000
+21.8%
643,349
+19.0%
0.40%
+24.4%
MASS Buy908 DEVICES INC$20,545,000
-7.3%
631,752
+10.5%
0.39%
-5.6%
DAR BuyDARLING INGREDIENTS INC$20,410,000
+36.3%
283,871
+28.0%
0.39%
+38.7%
THRM BuyGENTHERM INC$20,051,000
+24.8%
247,754
+9.5%
0.38%
+27.1%
TCBI BuyTEXAS CAP BANCSHARES INC$19,627,000
+25.7%
327,004
+33.0%
0.37%
+27.8%
PSTG BuyPURE STORAGE INCcl a$19,100,000
+129.7%
759,141
+78.3%
0.36%
+133.5%
NewENOVIX CORPORATION$18,885,000999,757
+100.0%
0.36%
VCEL BuyVERICEL CORP$18,665,000
-2.4%
382,479
+5.0%
0.35%
-0.6%
KNSL BuyKINSALE CAP GROUP INC$17,316,000
+27.6%
107,086
+30.1%
0.33%
+30.0%
PRFT BuyPERFICIENT INC$17,006,000
+44.0%
146,981
+0.1%
0.32%
+46.8%
MITK NewMITEK SYS INC$15,949,000862,124
+100.0%
0.30%
MTRN BuyMATERION CORP$15,933,000
-1.7%
232,121
+7.9%
0.30%0.0%
AERI BuyAERIE PHARMACEUTICALS INC$15,895,000
-28.5%
1,394,270
+0.5%
0.30%
-27.1%
POWI BuyPOWER INTEGRATIONS INC$15,002,000
+37.0%
151,555
+13.6%
0.28%
+39.7%
NMRK BuyNEWMARK GROUP INCcl a$14,320,000
+29.1%
1,000,677
+8.3%
0.27%
+31.4%
RPD BuyRAPID7 INC$14,103,000
+29.8%
124,779
+8.6%
0.27%
+32.7%
SIMO BuySILICON MOTION TECHNOLOGY COsponsored adr$13,074,000
+39.0%
189,526
+29.2%
0.25%
+41.7%
BCRX BuyBIOCRYST PHARMACEUTICALS INC$12,472,000
+73.8%
867,920
+91.2%
0.24%
+76.9%
PACB BuyPACIFIC BIOSCIENCES CALIF IN$11,556,000
+17.2%
452,302
+60.4%
0.22%
+19.0%
CEVA BuyCEVA INC$11,110,000
+29.3%
260,367
+43.3%
0.21%
+31.9%
HBIO BuyHARVARD BIOSCIENCE INC$11,026,000
-14.0%
1,579,655
+2.6%
0.21%
-12.6%
CERS BuyCERUS CORP$10,921,000
+180.9%
1,793,255
+172.6%
0.21%
+187.5%
SPRO BuySPERO THERAPEUTICS INC$10,229,000
+120.3%
555,614
+67.0%
0.19%
+123.0%
ADF NewALDEL FINANCIAL INC$10,234,0001,014,242
+100.0%
0.19%
RNLX NewRENALYTIX PLCads$9,983,000497,930
+100.0%
0.19%
NTRA BuyNATERA INC$9,667,000
+130.7%
86,750
+135.0%
0.18%
+134.6%
CTSO BuyCYTOSORBENTS CORP$9,375,000
+23.7%
1,154,561
+15.0%
0.18%
+26.2%
VG BuyVONAGE HLDGS CORP$9,321,000
+14.8%
578,235
+2.7%
0.18%
+17.2%
HCAT BuyHEALTH CATALYST INC$9,073,000
+8.7%
181,414
+20.6%
0.17%
+10.3%
SIBN BuySI-BONE INC$8,408,000
-25.4%
392,546
+9.6%
0.16%
-23.8%
WNS BuyWNS HLDGS LTDspon adr$8,234,000
+2.4%
100,665
+0.0%
0.16%
+4.0%
PLSE NewPULSE BIOSCIENCES INC$7,901,000365,765
+100.0%
0.15%
MPAA BuyMOTORCAR PTS AMER INC$7,604,000
+1500.8%
389,926
+1740.7%
0.14%
+1500.0%
RDWR BuyRADWARE LTDord$7,502,000
+11.9%
222,488
+2.2%
0.14%
+13.6%
AMWL BuyAMERICAN WELL CORPcl a$7,014,000
+41.5%
769,871
+95.3%
0.13%
+44.6%
HDSN BuyHUDSON TECHNOLOGIES INC$6,973,000
+400.9%
1,975,220
+382.4%
0.13%
+407.7%
VECO BuyVEECO INSTRS INC DEL$6,313,000
+26.4%
284,237
+36.8%
0.12%
+29.0%
AXTI BuyAXT INC$6,337,000
-3.1%
760,769
+27.7%
0.12%
-1.6%
SMED BuySHARPS COMPLIANCE CORP$6,211,000
-15.0%
751,054
+5.9%
0.12%
-13.2%
AMBA NewAMBARELLA INC$6,190,00039,748
+100.0%
0.12%
STIM BuyNEURONETICS INC$5,774,000
-50.6%
880,203
+20.6%
0.11%
-49.5%
CRVL NewCORVEL CORP$5,609,00030,122
+100.0%
0.11%
WIX BuyWIX COM LTD$5,407,000
+17.5%
27,591
+74.1%
0.10%
+19.8%
QLYS BuyQUALYS INC$5,205,000
+13.0%
46,772
+2.2%
0.10%
+15.1%
HSKA NewHESKA CORP$5,069,00019,605
+100.0%
0.10%
SLAB BuySILICON LABORATORIES INC$4,746,000
-3.6%
33,862
+5.4%
0.09%
-2.2%
LLNW BuyLIMELIGHT NETWORKS INC$4,628,000
-21.0%
1,944,533
+4.6%
0.09%
-19.3%
BMRA BuyBIOMERICA INC$4,641,000
+12.5%
1,031,358
+0.3%
0.09%
+14.3%
KNSA NewKINIKSA PHARMACEUTICALS LTD$4,622,000405,834
+100.0%
0.09%
OLK NewOLINK HLDG ABsponsored ads$4,506,000185,830
+100.0%
0.08%
RDUS BuyRADIUS HEALTH INC$4,404,000
-19.0%
354,888
+19.0%
0.08%
-16.8%
FATE NewFATE THERAPEUTICS INC$4,415,00074,492
+100.0%
0.08%
CTG BuyCOMPUTER TASK GROUP INC$4,308,000
-15.1%
539,873
+2.9%
0.08%
-13.7%
SWIR BuySIERRA WIRELESS INC$3,955,000
+378.8%
255,176
+486.8%
0.08%
+400.0%
IMGN NewIMMUNOGEN INC$3,842,000677,618
+100.0%
0.07%
RCUS NewARCUS BIOSCIENCES INC$3,656,000104,848
+100.0%
0.07%
RVNC NewREVANCE THERAPEUTICS INC$3,573,000128,239
+100.0%
0.07%
ARCT NewARCTURUS THERAPEUTICS HLDGS$3,496,00073,177
+100.0%
0.07%
NewCARIBOU BIOSCIENCES INC$3,388,000141,951
+100.0%
0.06%
PRTA NewPROTHENA CORP PLC$3,227,00045,304
+100.0%
0.06%
MLAB NewMESA LABS INC$3,227,00010,672
+100.0%
0.06%
SGMO BuySANGAMO THERAPEUTICS INC$3,140,000
+13.4%
348,473
+50.6%
0.06%
+15.4%
PRLB BuyPROTO LABS INC$3,104,000
-2.2%
46,611
+34.8%
0.06%0.0%
BuyDERMTECH INC$3,077,000
+705.5%
95,824
+943.5%
0.06%
+728.6%
ME New23ANDME HOLDING CO$2,776,000306,416
+100.0%
0.05%
VERI BuyVERITONE INC$2,197,000
+53.5%
91,950
+26.7%
0.04%
+55.6%
ELY NewCALLAWAY GOLF CO$2,020,00073,107
+100.0%
0.04%
XENE BuyXENON PHARMACEUTICALS INC$1,281,000
-17.4%
83,854
+0.7%
0.02%
-17.2%
XERS BuyXERIS PHARMACEUTICALS INC$1,139,000
-37.9%
465,049
+3.2%
0.02%
-35.3%
RCEL BuyAVITA MEDICAL INC$282,000
+7.2%
15,907
+24.1%
0.01%0.0%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

  • Destra Capital Advisors LLC #1
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-11-15
Signatures

The EDGAR filing(s) were signed by:

About Granahan Investment Management

Granahan Investment Management is a Boston-based investment firm that specializes in small-cap growth equity strategies. The firm was founded in 1985 by Jane Granahan and her late husband, Gerald Granahan, who was a pioneer in the small-cap growth investing space. Today, the firm is led by CEO and Chief Investment Officer Gary Hatton, who has been with the firm since 1993.

Granahan Investment Management has a team of experienced investment professionals who conduct extensive research to identify high-growth companies with strong fundamentals and attractive valuations. The firm's investment process is focused on bottom-up stock selection, with a long-term investment horizon. The team seeks to invest in companies with sustainable competitive advantages, strong management teams, and attractive growth prospects.

The firm manages several mutual funds, including the Granahan Small Cap Advantage Fund, which has a 5-star Morningstar rating and has outperformed its benchmark over the long term. The firm also manages separate accounts for institutional clients.

Granahan Investment Management has a strong culture of integrity, teamwork, and client service. The firm's investment professionals are committed to delivering superior investment results and building long-term relationships with their clients.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
COSTAR GROUP INC42Q3 20234.7%
SPS COMM INC42Q3 20233.5%
EURONET WORLDWIDE, INC42Q3 20231.7%
OSI SYSTEMS INC42Q3 20232.4%
RBC BEARINGS INC42Q3 20231.5%
DOUGLAS DYNAMICS INC42Q3 20231.0%
PROS HOLDINGS INC42Q3 20230.8%
RADWARE LTD42Q3 20231.3%
RUSH ENTERPRISES INC42Q3 20231.1%
POWER INTEGRATIONS INC42Q3 20230.9%

View Granahan Investment Management's complete holdings history.

Latest significant ownerships (13-D/G)
Granahan Investment Management Q3 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Evolent Health, Inc.February 14, 20233,155,2113.1%
SHOTSPOTTER, INCFebruary 14, 2023552,6254.5%
ALTA EQUIPMENT GROUP INC.February 14, 20221,453,5474.5%
CF Finance Acquisition Corp.Sold outFebruary 14, 202200.0%
Cricut, Inc.February 14, 20221,779,1274.9%
NAUTILUS, INC.Sold outFebruary 14, 202200.0%
ONESPAWORLD HOLDINGS LtdFebruary 14, 20222,978,8074.0%
Victory Capital Holdings, Inc.February 14, 2022879,6081.3%
dMY Technology Group, Inc. IISold outMay 11, 202100.0%
RumbleON, Inc.January 21, 202140,8771.9%

View Granahan Investment Management's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View Granahan Investment Management's complete filings history.

Compare quarters

Export Granahan Investment Management's holdings